Items per page
1 - 63 of 63
Title Published in Access level OA Policy Year Views Downloads
Prioritising at-risk adults in vaccine coadministration trialsThe Lancet. Infectious diseases
accessLevelRestricted
2025 1 0
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infectionPediatric allergy and immunology
accessLevelPublic
2024 123 133
B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patientsHuman vaccines & immunotherapeutics
accessLevelPublic
2024 2 0
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapyBMJ oncology
accessLevelPublic
2024 2 0
Mise à jour des vaccins chez les personnes âgéesRevue médicale suisse
accessLevelRestricted
2024 60 0
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
accessLevelPublic
2023 87 92
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 199 43
High-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arraysNature biomedical engineering
accessLevelPublic
2023 108 105
COVID-19 Vaccine Development - where do we stand?
accessLevelRestricted
2022 281 16
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
accessLevelPublic
2022 242 146
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipientsCurrent opinion in infectious diseases
accessLevelPublic
2022 68 293
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsScientific reports
accessLevelPublic
2022 112 15
Gynécologie-obstétrique - Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021Revue médicale suisse
accessLevelPublic
2022 76 42
A comparison of Sars-Cov-2 vaccine platforms : the CoviCompare projectNature medicine
accessLevelPublic
2022 65 72
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 84 0
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaNature
accessLevelPublic
2022 1,449 207
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
accessLevelPublic
2022 225 34
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
accessLevelPublic
2022 439 126
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
accessLevelPublic
2022 283 153
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipientsAnnals of oncology
accessLevelPublic
2022 255 83
Contrasting behavior between the three human monocyte subsets in dengue pathophysiologyiScience
accessLevelPublic
2022 69 28
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 195 132
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation : An updated EASL position paperJournal of hepatology
accessLevelPublic
2022 61 140
Is there a role for childhood vaccination against COVID-19?Pediatric allergy and immunology
accessLevelRestricted
2021 272 1
Maladies infectieusesRevue médicale suisse
accessLevelPublic
2021 385 95
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 372 38
Defining HPV-specific B cell responses in patients with head and neck cancerNature
accessLevelRestricted
2021 116 0
The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody TransferVaccines
accessLevelPublic
2021 110 114
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 434 235
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
accessLevelPublic
2021 521 305
Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor TherapyVaccines
accessLevelPublic
2021 73 106
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 307 126
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipientsBone marrow transplantation
accessLevelRestricted
2021 329 2
Influenza Immunization in the Context of Preexisting ImmunityCold Spring Harbor perspectives in medicine
accessLevelPublic
2021 54 22
Coronavirus disease 2019 vaccination in transplant recipientsCurrent opinion in infectious diseases
accessLevelRestricted
2021 107 0
Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19Journal of the Pediatric Infectious Diseases Society
accessLevelPublic
2021 328 72
Paradoxes and Uncertainties of Immunomodulatory Treatments in the Fight Against Coronavirus Disease 2019Clinical infectious diseases
accessLevelPublic
2021 212 82
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
accessLevelPublic
2021 403 200
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
accessLevelPublic
2021 407 245
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivityClinical microbiology and infection
accessLevelRestricted
2021 694 0
Faudra-t-il vacciner les enfants contre le Covid-19 ?Revue médicale suisse
accessLevelPublic
2021 75 50
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipientsJournal of hepatology
accessLevelPublic
2021 90 127
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancerNature
accessLevelRestricted
2021 136 0
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipientsJournal of hepatology
accessLevelPublic
2021 91 86
Multi-stage group testing improves efficiency of large-scale COVID-19 screeningJournal of Clinical Virology
accessLevelRestricted
2020 308 0
Persistence of varicella-zoster virus-specific plasma cells in adult human bone marrow following childhood vaccinationJournal of Virology
accessLevelRestricted
2020 435 0
Challenges and issues of SARS-CoV-2 pool testingThe Lancet Infectious Diseases
accessLevelRestricted
2020 312 4
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 517 195
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centersCell Reports
accessLevelPublic
2019 320 197
Does Maternal Tdap Vaccination During Pregnancy Increase the Risk of Developing Chorioamnionitis? - A Monocentric, Retrospective, Observational Study
accessLevelRestricted
2019 102 4
Characterization of virus-specific immune response during varicella zoster virus encephalitis in a young adultClinical Infectious Diseases
accessLevelRestricted
2019 313 0
Understanding the immunology of the Zostavax shingles vaccineCurrent Opinion in Immunology
accessLevelRestricted
2019 287 0
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
accessLevelPublic
2018 495 452
Review of maternal immunisation during pregnancy: focus on pertussis and influenzaSwiss Medical Weekly
accessLevelPublic
2017 349 177
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
accessLevelPublic
2017 619 255
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementationThe Journal of Maternal - Fetal & Neonatal Medicine
accessLevelRestricted
2017 459 0
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
accessLevelRestricted
2016 747 5
Recommandations de vaccination chez la femme enceinte : une piqûre de rappelRevue médicale suisse
accessLevelRestricted
2016 410 2
Reply to Abu Raya et alClinical infectious diseases
accessLevelRestricted
2016 432 3
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeThe Journal of immunology
accessLevelRestricted
2015 674 2
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of conceptVaccine
accessLevelPublic
2015 614 180
The Seatbelt Syndrome-Do We Have a Chance?: A Report of 3 Cases With Review of LiteraturePediatric emergency care
accessLevelRestricted
2015 566 2
Cholestasis as the leading sign of a transmesenteric hernia in a split-liver transplanted child - a case report and review of literaturePediatric transplantation
accessLevelRestricted
2012 653 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack